You searched for T cells - Page 29 of 41

News and Trends 3 Jun 2020

What Did European Oncology Players Offer at ASCO 2020?

…type of cell therapy where the patient’s immune T-cells are genetically modified to hunt down blood cancer cells. The trial enrolled 29 patients to test the effect of Janssen’s therapy,…

June 3, 2020 - 10 minutesmins - By Jonathan Smith

News and Trends 7 Dec 2015

Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons

…two heads everytime one was cut off…Well, it turns out that the myth wasn’t that far from reality. Researchers at University of Geneva (UNIGE) have discovered the polyps of freshwater…

December 7, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 27 Sep 2024

Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders

…a drug that takes the shape of an aptamer – single-stranded molecules that bind to targets. “In order to make this suitable for clinical development, we transform it, the non-coding…

September 27, 2024 - 6 minutesmins - By Roohi Mariam Peter

bioreactor, cell culture expansion, perfusion, biomanufacturing

How to Make Cell Culture Expansion Easy

…if they need to inoculate this at 10,000-liter bioreactor volumes, they can scale that process up in the Xcellerex APS system.” In fact, scalability is a significant benefit of the…

January 18, 2022 - 7 minutesmins - By Sudha Sundaram

nature cancer reviews lumd leiden isa pharmaceuticals immuno oncology immunotherapies checkpointblocking chemotherapy immunosupression

News and Trends 11 Mar 2016

Reviewing Immuno-Oncology: What works and what doesn’t

…that attack the tumor. Raising tumor-specific T-cells to target tumors is successful in most cases. However, doing so does not necessarily mean that T-cells can perform their function within the…

March 11, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 27 Feb 2020

Scientists Connect Brain Cells to Machines Over the Internet

…interfaces is that lots of time, effort and money are needed to get experts and specialist equipment in one place to link up. This is what the researchers, based in…

February 27, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Apr 2023

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

…protein is a new target in the fight against cancer. Targeting cell division is not new, but using RNA to target proteins that make up the cell’s skeleton (cytoskeleton) –…

April 24, 2023 - 4 minutesmins - By Jim Cornall

In Depth 18 Nov 2024

What is Abcam’s founder, Jonathan Milner, up to?

…cancer types. By leveraging these antigens, Epitopea aims to develop therapies that enable the immune system to specifically target and destroy cancer cells while minimizing harm to normal tissues. What…

November 18, 2024 - 17 minutesmins - By Jules Adam

Interview 14 Sep 2017

Inside the Lab Building a Stem Cell Gun to Heal Skin

…fast routes to receive and send fresh samples to their network of collaborators. “The first time we thought it was so cool to just walk out of the lab and…

September 14, 2017 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Jul 2023

Existing cancer drug could be repurposed to fight certain aggressive cancers

…through alternative pathways, rather than activating telomerase. This mechanism is known as the alternative lengthening of telomeres (ALT). To date, there is no clinically approved targeted treatment for ALT cancers….

July 10, 2023 - 5 minutesmins - By Jim Cornall

Best in Biotech 23 Mar 2023

Hearing loss research: Five advancements in the past year

…which had an activated brainstem learned faster and responded to the tasks quicker. These rats completed the auditory task within three days while those that did not receive the boost…

March 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

In Depth 9 Oct 2024

Promising cure for COPD: Is a breakthrough treatment within reach?

…This makes the drug the first biological treatment for patients with COPD in the U.S. Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and…

October 9, 2024 - 9 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: T cells

What Did European Oncology Players Offer at ASCO 2020?

Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons

Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders

How to Make Cell Culture Expansion Easy

Reviewing Immuno-Oncology: What works and what doesn’t

Scientists Connect Brain Cells to Machines Over the Internet

RNA-based nanodrugs cause cancer cells to collapse – 80% survival rate for ovarian cancer in lab models

What is Abcam’s founder, Jonathan Milner, up to?

Inside the Lab Building a Stem Cell Gun to Heal Skin

Existing cancer drug could be repurposed to fight certain aggressive cancers

Hearing loss research: Five advancements in the past year

Promising cure for COPD: Is a breakthrough treatment within reach?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!